Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase… bypharmanewsdailyMarch 31, 2019